If youve been told you have peritoneal pockets, our team can help you understand what that finding may mean in your casebased on your symptoms, imaging, and whether deeper structures (like bowel, bladder, or ureters) could also be involved.
However, it is crucial to understand that no GLP-1 patches are currently licensed by the MHRA in the UK
Patients with established cardiovascular disease may benefit from specific GLP-1 therapies (semaglutide, dulaglutide, or liraglutide) that have demonstrated cardiovascular risk reduction in clinical trials, though these benefits are observed during active treatment
The central question is no longer just whether a clear statistical link exists, but whether manufacturers and regulators exercised appropriate caution while long-term, real-world data is still developing
During your first few weeks of GLP-1 treatment, stay in contact with your doctor
They suppress appetite and promote weight loss, but they dont nourish your cells, replete missing nutrients, or correct hormonal signaling
